Viewing StudyNCT06454448

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06454448
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-06
Brief Title: Phase IbII Clinical Study of Adebrelimab in Combination With Decitabine Albumin-bound Paclitaxel and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization: Tianjin Medical University Cancer Institute and Hospital
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Pancreatic Cancer
Adebrelimab SHR-1316
Decitabine
Keywords: